Clinical Center News
October / November 2023

Participants needed in clinical trial at the NIH Clinical Center

a gloved medical professional holding a capsule

Diamond-Blackfan anemia (DBA) is an inherited disorder that occurs when the bone marrow fails to make red blood cells, leading to anemia and bone marrow failure, with increased cancer risks.

Researchers at the National Institutes of Health want to know if the investigational drug Bitopertin is safe and effective in helping restore blood formation by targeting one of the defects found in patients with DBA. If you or someone you know has been diagnosed with DBA and have not responded to therapy, has relapsed, or is not able to tolerate current treatment; you may be eligible to participate in this study. There is no cost for tests, treatments or procedures, and travel, food and lodging may be provided.

To learn more about this study, contact the NIH Clinical Center Office of Patient Recruitment at 866-444-2214 (TTY users dial 7-1-1), or visit Ask for study #001528-H.

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at